Literature DB >> 35604612

Insulin-like growth factor I sensitization rejuvenates sleep patterns in old mice.

Jonathan A Zegarra-Valdivia1,2,3,4, Jansen Fernandes1,5, Maria Estrella Fernandez de Sevilla1,2, Angel Trueba-Saiz1,2, Jaime Pignatelli1,2, Kentaro Suda1,6, Laura Martinez-Rachadell1,2, Ana Maria Fernandez1,2, Julio Esparza1, Miguel Vega7, Angel Nuñez8, Ignacio Torres Aleman9,10,11.   

Abstract

Sleep disturbances are common during aging. Compared to young animals, old mice show altered sleep structure, with changes in both slow and fast electrocorticographic (ECoG) activity and fewer transitions between sleep and wake stages. Insulin-like growth factor I (IGF-I), which is involved in adaptive changes during aging, was previously shown to increase ECoG activity in young mice and monkeys. Furthermore, IGF-I shapes sleep architecture by modulating the activity of mouse orexin neurons in the lateral hypothalamus (LH). We now report that both ECoG activation and excitation of orexin neurons by systemic IGF-I are abrogated in old mice. Moreover, orthodromical responses of LH neurons are facilitated by either systemic or local IGF-I in young mice, but not in old ones. As orexin neurons of old mice show dysregulated IGF-I receptor (IGF-IR) expression, suggesting disturbed IGF-I sensitivity, we treated old mice with AIK3a305, a novel IGF-IR sensitizer, and observed restored responses to IGF-I and rejuvenation of sleep patterns. Thus, disturbed sleep structure in aging mice may be related to impaired IGF-I signaling onto orexin neurons, reflecting a broader loss of IGF-I activity in the aged mouse brain.
© 2022. The Author(s), under exclusive licence to American Aging Association.

Entities:  

Keywords:  Aging; Cortical activation; IGF-I; Orexinergic neurons; Rejuvenation; Sleep

Year:  2022        PMID: 35604612     DOI: 10.1007/s11357-022-00589-1

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  66 in total

Review 1.  A conserved regulatory system for aging.

Authors:  C Kenyon
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

Review 2.  The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness.

Authors:  Takeshi Sakurai
Journal:  Nat Rev Neurosci       Date:  2007-02-14       Impact factor: 34.870

3.  Insulin-like growth factor I modulates sleep through hypothalamic orexin neurons.

Authors:  Jonathan A Zegarra-Valdivia; Jaime Pignatelli; Maria Estrella Fernandez de Sevilla; Ana M Fernandez; Victor Munive; Laura Martinez-Rachadell; Angel Nuñez; Ignacio Torres Aleman
Journal:  FASEB J       Date:  2020-10-08       Impact factor: 5.191

Review 4.  Impaired insulin action in the human brain: causes and metabolic consequences.

Authors:  Martin Heni; Stephanie Kullmann; Hubert Preissl; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2015-10-13       Impact factor: 43.330

5.  Caloric restriction modulates insulin receptor signaling in liver and skeletal muscle of rat.

Authors:  Min Zhu; Rafael de Cabo; R Michael Anson; Donald K Ingram; Mark A Lane
Journal:  Nutrition       Date:  2005-03       Impact factor: 4.008

Review 6.  Sleep and Human Aging.

Authors:  Bryce A Mander; Joseph R Winer; Matthew P Walker
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

Review 7.  Sleep disorders, obesity, and aging: the role of orexin.

Authors:  Joshua P Nixon; Vijayakumar Mavanji; Tammy A Butterick; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Ageing Res Rev       Date:  2014-11-22       Impact factor: 10.895

Review 8.  Sleep and Alzheimer disease pathology--a bidirectional relationship.

Authors:  Yo-El S Ju; Brendan P Lucey; David M Holtzman
Journal:  Nat Rev Neurol       Date:  2013-12-24       Impact factor: 42.937

Review 9.  The insulin paradox: aging, proteotoxicity and neurodegeneration.

Authors:  Ehud Cohen; Andrew Dillin
Journal:  Nat Rev Neurosci       Date:  2008-09-04       Impact factor: 34.870

Review 10.  A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin.

Authors:  Mark P Mattson; Stuart Maudsley; Bronwen Martin
Journal:  Ageing Res Rev       Date:  2004-11       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.